Semaglutide can also be beneficial to people with type 1 diabetes, clinical trial finds

Semaglutide (known by its brand name Ozempic) has gained widespread attention for its weight-loss benefits, but is officially approved for managing type 2 diabetes. While there is currently limited data on its risks and benefits for those with type 1 diabetes, new research offers promising insights.

Leave A Comment

Your email address will not be published. Required fields are marked *